Kynurenines in the CNS: recent advances and new questions.
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesThe mysterious case of the C. elegans gut granule: death fluorescence, anthranilic acid and the kynurenine pathwayCurrent Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisKynurenine Aminotransferase Isozyme Inhibitors: A ReviewChronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advancesIndoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's DiseaseElectron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial BioenergeticsKynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous SystemImmunomodulatory effects mediated by serotoninChanging the face of kynurenines and neurotoxicity: therapeutic considerationsMolecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenaseTargeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAINMicrobiota alteration is associated with the development of stress-induced despair behaviorStress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intoleranceEnantioselective total syntheses of plectosphaeroic acids B and C.Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice.Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat.High-Fat Diet and Voluntary Chronic Aerobic Exercise Recover Altered Levels of Aging-Related Tryptophan Metabolites along the Kynurenine Pathway.B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women.Targets for future clinical trials in Huntington's disease: what's in the pipeline?Crystal Structures and Structure-Activity Relationships of Imidazothiazole Derivatives as IDO1 InhibitorsKynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis.High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice.Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative DiseaseDetermination of l-tryptophan and l-kynurenine derivatized with (R)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl)-2,1,3-benzoxadiazole by LC-MS/MS on a triazole-bonded column and their quantification in human serum.Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study).Discovery of a Novel Scaffold as an Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Based on the Pyrrolopiperazinone Alkaloid, Longamide B.Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion.Transcriptome analysis reveals mucin 4 to be highly associated with periodontitis and identifies pleckstrin as a link to systemic diseases.What do drug transporters really do?Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health StudyAltered serum levels of kynurenine metabolites in patients affected by cluster headacheAltered kynurenine pathway metabolites in serum of chronic migraine patientsThe tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseasesTryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.Determination of l-tryptophan and l-kynurenine in Human Serum by using LC-MS after Derivatization with (R)-DBD-PyNCS.
P2860
Q21129356-F1CC2E08-107D-40F7-8A40-846C4A7B1ACFQ21131240-59361C67-BAA0-4DDB-A319-19C9CAB34CD6Q26740330-8E260522-6BEC-4A67-BEC1-C3062F1C84ADQ26744492-BA52C5A5-283E-4835-827A-090019C80DEBQ26770781-4C1D74A3-CBB9-4D69-B6D0-4B03C414779CQ26775316-82BE5988-3789-4625-996F-1E6FF0939089Q26781849-23A31C95-DEAF-4D2A-ADF1-A6CF3E0F7D86Q26795417-F5431066-FD09-4F16-80AF-A4EA6F015CFAQ26796667-73BE3D4F-A180-4DD8-96F6-36559BAEC4A9Q28084203-838B35A8-41B0-494C-99ED-0DC147C8CA97Q28085041-ACE998D1-93D7-4ACE-B18F-1FE8E1FB4E7DQ28115713-84AC659A-BF6C-46A1-85C6-1DDF6BC22B9EQ29306917-1D9AD400-52A3-4D16-B5E8-5E0302881F4DQ30253023-3DA16FF2-DD74-44CD-B1D3-0858837C7B7AQ30426795-E70AD7A4-ECF6-45A2-9424-859E7E9F1EC9Q30556998-7A98D5E6-E0B7-4769-BB7D-1424EA0488FCQ30654478-CD0F78D6-1E36-4029-8863-F106578D0360Q31141746-8C8D5BD1-D957-4D69-AAAB-155EF89BE6ECQ33794568-83886328-0FDE-4570-A527-5A77BDF15984Q33854563-79296123-4231-4B09-9252-240DA82A4215Q34169250-9FFB5776-86A3-49A5-8D4D-CB36536235C4Q34435001-A0603011-205D-4471-8AD0-48E70A52792AQ34443476-F8E71F7A-747E-4375-99B4-5C056867A3C0Q34508486-1E5D67BE-1944-4FCF-AC11-55E77F71002EQ35175306-19EFEB5C-FEBE-4378-AAD1-8D269D4DEB5AQ35554122-7D589CCD-1E7B-4F0C-8999-949A8DC4E5ECQ35788146-351B9A41-D2F0-4DE9-861A-0F33DCE37EFBQ35933940-F60CA637-A5D0-4D1C-81B6-B317C8DB95A0Q35938110-3725C546-3C64-4270-8550-5420544F3542Q36198024-191B0BFB-28BC-4E95-840D-B1BCB81E8FBDQ36256757-B11FB59D-859F-4B15-BF66-8C5D29B7A4D4Q36338957-F7D444D1-73CA-4E75-B2A7-5A3E467D1F99Q36388107-91CC7DFD-2D57-456B-A34B-63A7AAFFD32FQ36571217-799FDD00-BB63-4DF3-8D58-C729E51A0008Q36579036-FCCF3CB4-5B6A-454B-B601-EA4FE5026709Q36712255-23EDD65A-5B74-426A-A9FB-F01F0C7E13DBQ36853404-139AEE63-8888-44C3-BAB7-231994199BD1Q36984717-E63EE051-2931-4570-8BD4-8E31F45AAE41Q37013795-E0479898-7E99-4457-82D4-FD886308F5CAQ37059674-649F67DF-7570-44B1-853A-2CDC31768016
P2860
Kynurenines in the CNS: recent advances and new questions.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Kynurenines in the CNS: recent advances and new questions.
@ast
Kynurenines in the CNS: recent advances and new questions.
@en
Kynurenines in the CNS: recent advances and new questions.
@nl
type
label
Kynurenines in the CNS: recent advances and new questions.
@ast
Kynurenines in the CNS: recent advances and new questions.
@en
Kynurenines in the CNS: recent advances and new questions.
@nl
prefLabel
Kynurenines in the CNS: recent advances and new questions.
@ast
Kynurenines in the CNS: recent advances and new questions.
@en
Kynurenines in the CNS: recent advances and new questions.
@nl
P356
P1476
Kynurenines in the CNS: recent advances and new questions
@en
P2093
Ferenc Fülöp
József Toldi
P2888
P356
10.1038/NRD3793
P577
2012-12-14T00:00:00Z